Amici Capital’s Dynavax Technologies DVAX Stock Holding History

Amici Capital’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,501	Closed	-$2.62M	–	68
2016 Q3	$2.62M	Buy	+2,501	New	+$35.9K	0.69%	43

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Amici Capital's DVAX Position: Q1 2017 in Review

Amici Capital sold out of Dynavax Technologies (DVAX) in Q1 2017, closing a stake of 100,000 shares — an estimated $395K sold.

Amici Capital first reported a position in DVAX in Q2 2013 and held it in 15 quarters. The position peaked at $60.2M in Q2 2015. 101 funds tracked by Wall St. Rank hold DVAX as of Q1 2017.

Amici Capital reported no remaining Dynavax Technologies position as of Q1 2017 after selling out during the quarter.
Amici Capital sold 100,000 Dynavax Technologies shares in Q1 2017, an estimated $395K.
Amici Capital first reported a position in Dynavax Technologies in Q2 2013 and held it in 15 quarters.
Amici Capital's Dynavax Technologies position peaked at $60.2M in Q2 2015.
101 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2017.

Based on Amici Capital's 13F filing for Q1 2017.